ANTI-SCHIZOPHRENIC DRUGS - MEMBRANE RECEPTOR-SITES OF ACTION

[21] DELAY J, 1952, Ann Med Psychol (Paris), V110, P267

[22] STEREOSPECIFICITY OF INTERACTION OF NEUROLEPTIC DRUGS WITH NEUROTRANSMITTERS AND CORRELATION WITH CLINICAL POTENCY [J]. NATURE, 1976, 263 (5575) : 338 - 341

[23] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) : 113 - 124

[24] RELATIONSHIP BETWEEN LIPOPHILIC NATURE OF TRICYCLIC NEUROLEPTICS AND ANTIDEPRESSANTS, AND HISTAMINE-RELEASE [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1972, 18 (02) : 139 - &

[25] EFFECT OF L-DOPA ON YOUNG PATIENTS WITH SIMPLE SCHIZOPHRENIA, TREATED WITH NEUROLEPTIC DRUGS - DOUBLE-BLIND CROSSOVER TRIAL WITH MADOPAR AND PLACEBO [J]. PSYCHOPHARMACOLOGIA, 1975, 44 (01): : 105 - 110

[26] GRUENER R, 1972, J PHARMACOL-PARIS, V181, P161

[27] HALARIS AE, 1975, BIOLOGY MAJOR PSYCHO, V54, P247

[28] HAMBERGER B, 1973, EUR J CLIN PHARMACOL, V5, P1

[29] HEIKKILA RE, 1976, RES COMMUN CHEM PATH, V13, P237

[30] COMMON MODE OF ACTION OF 3 AGENTS THAT DECREASE TRANSIENT CHANGE IN SODIUM PERMEABILITY IN NERVES [J]. NATURE, 1966, 210 (5042) : 1220 - &

[21] DELAY J, 1952, Ann Med Psychol (Paris), V110, P267

[22] STEREOSPECIFICITY OF INTERACTION OF NEUROLEPTIC DRUGS WITH NEUROTRANSMITTERS AND CORRELATION WITH CLINICAL POTENCY [J]. NATURE, 1976, 263 (5575) : 338 - 341

[23] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) : 113 - 124

[24] RELATIONSHIP BETWEEN LIPOPHILIC NATURE OF TRICYCLIC NEUROLEPTICS AND ANTIDEPRESSANTS, AND HISTAMINE-RELEASE [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1972, 18 (02) : 139 - &

[25] EFFECT OF L-DOPA ON YOUNG PATIENTS WITH SIMPLE SCHIZOPHRENIA, TREATED WITH NEUROLEPTIC DRUGS - DOUBLE-BLIND CROSSOVER TRIAL WITH MADOPAR AND PLACEBO [J]. PSYCHOPHARMACOLOGIA, 1975, 44 (01): : 105 - 110

[26] GRUENER R, 1972, J PHARMACOL-PARIS, V181, P161

[27] HALARIS AE, 1975, BIOLOGY MAJOR PSYCHO, V54, P247

[28] HAMBERGER B, 1973, EUR J CLIN PHARMACOL, V5, P1

[29] HEIKKILA RE, 1976, RES COMMUN CHEM PATH, V13, P237

[30] COMMON MODE OF ACTION OF 3 AGENTS THAT DECREASE TRANSIENT CHANGE IN SODIUM PERMEABILITY IN NERVES [J]. NATURE, 1966, 210 (5042) : 1220 - &